bpc 157 cartilage repair tendon to bone integration Application of peptide therapy for ligaments and tendons: A narrative review Modulation of early functional recovery – bpc 157 cartilage regeneration Therapeutic

Toxicology assessments in rats found no organ toxicity at doses up to 10 mg/kg (approximately 1000x the effective dose), no mutagenicity in Ames testing, and no teratogenic effects

Most common route Oral capsule, 50 to 150 mg per day, taken in the morning

B12 deficiency in particular can cause megaloblastic anemia

Yes, Medicaid covers this code in most states when the injection is medically necessary

This provides the convenience of nasal administration for the systemically-acting peptide while maintaining local concentration of BPC-157 where targeted healing is desired

B12 is water-soluble, and its generally safe even at very high doses